UK markets open in 3 hours 5 minutes
NIKKEI 225
38,287.01 +12.96 (+0.03%) HANG SENG
18,098.96 +335.93 (+1.89%) CRUDE OIL
79.44 +0.44 (+0.56%) GOLD FUTURES
2,328.10 +17.10 (+0.74%) DOW
37,903.29 +87.37 (+0.23%) Bitcoin GBP
45,872.72 -2,161.29 (-4.50%)
China SXT Pharmaceuticals, Inc. (SXTC)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.0600 |
| Open | 1.0600 |
| Bid | 0.7488 x 200 |
| Ask | 1.3000 x 200 |
| Day's range | 1.0000 - 1.0700 |
| 52-week range | 0.9400 - 9.3750 |
| Volume | |
| Avg. volume | 1,136,683 |
| Market cap | 576,843 |
| Beta (5Y monthly) | 1.03 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -26.9600 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireChina SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price Rule
TAIZHOU, China, Oct. 26, 2023 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company"), (NASDAQ: SXTC), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements ("TCMHS"), today announced that on October 19, 2023, NASDAQ notified us that it ha
Simply Wall St.China SXT Pharmaceuticals Full Year 2023 Earnings: US$0.89 loss per share (vs US$5.52 loss in FY 2022)
China SXT Pharmaceuticals ( NASDAQ:SXTC ) Full Year 2023 Results Key Financial Results Net loss: US$5.93m (loss widened...
© 2024 Yahoo. All rights reserved.